Search Results - "Kasiske, B. L."

OPTN/SRTR 2011 Annual Data Report: Kidney by Matas, A. J., Smith, J. M., Skeans, M. A., Lamb, K. E., Gustafson, S. K., Samana, C. J., Stewart, D. E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT  A shortage of kidneys for transplant remains a major problem for patients with end‐stage renal disease. The number of candidates on the waiting list…”
Get full text

OPTN/SRTR 2011 Annual Data Report: Liver by Kim, W. R., Stock, P. G., Smith, J. M., Heimbach, J. K., Skeans, M. A., Edwards, E. B., Harper, A. M., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT  The current liver allocation system, introduced in 2002, decreased the importance of waiting time for allocation priorities; the number of active…”
Get full text

Predicting Coronary Heart Disease after Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study by Israni, A. K., Snyder, J. J., Skeans, M. A., Peng, Y., Maclean, J. R., Weinhandl, E. D., Kasiske, B. L.

“…Traditional risk factors do not adequately explain coronary heart disease (CHD) risk after kidney transplantation. We used a large, multicenter database to…”
Get full text

Lung and Heart Allocation in the United States by Colvin‐Adams, M., Valapour, M., Hertz, M., Heubner, B., Paulson, K., Dhungel, V., Skeans, M. A., Edwards, L., Ghimire, V., Waller, C., Cherikh, W. S., Kasiske, B. L., Snyder, J. J., Israni, A. K.

“…Lung and heart allocation in the United States has evolved over the past 20–30 years to better serve transplant candidates and improve organ utilization. The…”
Get full text

Predicting End‐Stage Renal Disease After Liver Transplant by Israni, A. K., Xiong, H., Liu, J., Salkowski, N., Trotter, J. F., Snyder, J. J., Kasiske, B. L.

“…Few equations have been developed to predict end‐stage renal disease (ESRD) after deceased donor liver transplant. This retrospective observational cohort…”
Get full text

OPTN/SRTR 2011 Annual Data Report: Lung by Valapour, M., Paulson, K., Smith, J. M., Hertz, M. I., Skeans, M. A., Heubner, B. M., Edwards, L. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT  Lungs are allocated in part based on the Lung Allocation Score (LAS), which considers risk of death without transplant and posttransplant. Wait‐list…”
Get full text

Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial by Weiner, D. E., Carpenter, M. A., Levey, A. S., Ivanova, A., Cole, E. H., Hunsicker, L., Kasiske, B. L., Kim, S. J., Kusek, J. W., Bostom, A. G.

“…In kidney transplant recipients, cardiovascular disease (CVD) is the leading cause of death. The relationship of kidney function with CVD outcomes in…”
Get full text

Bayesian Methods for Assessing Transplant Program Performance by Salkowski, N., Snyder, J. J., Zaun, D. A., Leighton, T., Israni, A. K., Kasiske, B. L.

“…Based on recommendations from a recent consensus conference and a report commissioned by the Centers for Medicare & Medicaid Services to the Committee of…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

OPTN/SRTR 2011 Annual Data Report: Pancreas by Kandaswamy, R., Stock, P. G., Skeans, M. A., Gustafson, S. K., Sleeman, E. F., Wainright, J. L., Carrico, R. J., Ghimire, V., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT  Numbers of pancreas transplants have been decreasing over the past decade, but outcomes continue to improve for all types: simultaneous…”
Get full text

OPTN/SRTR 2015 Annual Data Report: Early effects of the new kidney allocation system by Hart, A., Gustafson, S. K., Skeans, M. A., Stock, P., Stewart, D., Kasiske, B.L., Israni, A. K.

“…In December 2014, a new kidney allocation system (KAS) was implemented in the United States in an attempt to improve access to transplant for historically…”
Get full text

Kidney, Pancreas and Liver Allocation and Distribution in the United States by Smith, J. M., Biggins, S. W., Haselby, D. G., Kim, W. R., Wedd, J., Lamb, K., Thompson, B., Segev, D. L., Gustafson, S., Kandaswamy, R., Stock, P. G., Matas, A. J., Samana, C. J., Sleeman, E. F., Stewart, D., Harper, A., Edwards, E., Snyder, J. J., Kasiske, B. L., Israni, A. K.

“…Kidney transplant and liver transplant are the treatments of choice for patients with end‐stage renal disease and end‐stage liver disease, respectively…”
Get full text

Report of a Consensus Conference on Transplant Program Quality and Surveillance by Kasiske, B. L., McBride, M. A., Cornell, D. L., Gaston, R. S., Henry, M. L., Irwin, F. D., Israni, A. K., Metzler, N. W., Murphy, K. W., Reed, A. I., Roberts, J. P., Salkowski, N., Snyder, J. J., Sweet, S. C.

“…Public reports of organ transplant program outcomes by the US Scientific Registry of Transplant Recipients have been both groundbreaking and controversial. The…”
Get full text

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients by Kasiske, B. L., de Mattos, A., Flechner, S. M., Gallon, L., Meier‐Kriesche, H.‐U., Weir, M. R., Wilkinson, A.

“…The incidence, pathogenesis, consequences and treatment of mammalian target of rapamycin (mTOR) inhibitor dyslipidemia are not well described. We conducted a…”
Get full text

A Scientific Registry of Transplant Recipients Bayesian Method for Identifying Underperforming Transplant Programs by Salkowski, N., Snyder, J. J., Zaun, D. A., Leighton, T., Edwards, E. B., Israni, A. K., Kasiske, B. L.

“…In response to recommendations from a recent consensus conference and from the Committee of Presidents of Statistical Societies, the Scientific Registry of…”
Get full text

New Quality Monitoring Tools Provided by the Scientific Registry of Transplant Recipients: CUSUM by Snyder, J. J., Salkowski, N., Zaun, D., Leppke, S. N., Leighton, T., Israni, A. K., Kasiske, B. L.

“…The Scientific Registry of Transplant Recipients (SRTR) has been providing data on transplant program performance through semi‐annual release of…”
Get full text

Potential Implications of Recent and Proposed Changes in the Regulatory Oversight of Solid Organ Transplantation in the United States by Kasiske, B. L., Salkowski, N., Wey, A., Israni, A. K., Snyder, J. J.

“…Every 6 months, the Scientific Registry of Transplant Recipients (SRTR) publishes evaluations of every solid organ transplant program in the United States,…”
Get full text

OPTN/SRTR 2011 Annual Data Report: Heart by Colvin‐Adams, M., Smith, J. M., Heubner, B. M., Skeans, M. A., Edwards, L. B., Waller, C., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…ABSTRACT  Since 2005, the number of new active adult candidates on the heart transplant waiting list increased by 19.2%. The transplant rate peaked at 78.6 per…”
Get full text

Effect of Comorbidity Adjustment on CMS Criteria for Kidney Transplant Center Performance by Weinhandl, E. D., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…The Centers for Medicare & Medicaid Services (CMS) uses kidney transplant outcomes, unadjusted for standard comorbidity, to identify centers with sufficiently…”
Get full text

OPTN/SRTR 2011 Annual Data Report: Deceased Organ Donation by Israni, A. K., Zaun, D. A., Rosendale, J. D., Snyder, J. J., Kasiske, B. L.

“…ABSTRACT  In 2011, the number of eligible deaths (death of a patient aged 70 years or younger who is legally declared brain dead and does not exhibit any…”
Get full text